The Effects of PPAR Stimulation on Cardiac Metabolic Pathways in Barth Syndrome Mice.

about

The Effects of PPAR Stimulation on Cardiac Metabolic Pathways in Barth Syndrome Mice.

Item

http://www.wikidata.org/entity/Q52562680

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

The Effects of PPAR Stimulation on Cardiac Metabolic Pathways in Barth Syndrome Mice.

@en

The Effects of PPAR Stimulation on Cardiac Metabolic Pathways in Barth Syndrome Mice.

@nl

type

Item

label

The Effects of PPAR Stimulation on Cardiac Metabolic Pathways in Barth Syndrome Mice.

@en

The Effects of PPAR Stimulation on Cardiac Metabolic Pathways in Barth Syndrome Mice.

@nl

prefLabel

The Effects of PPAR Stimulation on Cardiac Metabolic Pathways in Barth Syndrome Mice.

@en

The Effects of PPAR Stimulation on Cardiac Metabolic Pathways in Barth Syndrome Mice.

@nl

P1476

The Effects of PPAR Stimulation on Cardiac Metabolic Pathways in Barth Syndrome Mice.

@en

P2093

Alexander I Glukhov

http://www.w3.org/2001/XMLSchema#string

Arnold W Strauss

http://www.w3.org/2001/XMLSchema#string

Caitlin Schafer

http://www.w3.org/2001/XMLSchema#string

Jeanne F James

http://www.w3.org/2001/XMLSchema#string

Nupur Dasgupta

http://www.w3.org/2001/XMLSchema#string

Sabzali Javadov

http://www.w3.org/2001/XMLSchema#string

Vicky Moore

http://www.w3.org/2001/XMLSchema#string

Zaza Khuchua

http://www.w3.org/2001/XMLSchema#string

P2860

Cardiac and skeletal muscle defects in a mouse model of human Barth syndrome

Characterization of a transgenic short hairpin RNA-induced murine model of Tafazzin deficiency

Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks

Molecular mechanism of peroxisome proliferator-activated receptor α activation by WY14643: a new mode of ligand recognition and receptor stabilization

Barth syndrome.

Bezafibrate for the secondary prevention of myocardial infarction in patients with metabolic syndrome

Osteocrin is a specific ligand of the natriuretic Peptide clearance receptor that modulates bone growth

Bezafibrate administration improves behavioral deficits and tau pathology in P301S mice

Peroxisome proliferator-activated receptor (PPAR)-alpha: a pharmacological target with a promising future

Evolution of Osteocrin as an activity-regulated factor in the primate brain

P304

318

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2018.00318

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29695963

http://www.w3.org/2001/XMLSchema#string

P932

5904206

http://www.w3.org/2001/XMLSchema#string